Schonfeld Strategic Advisors LLC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1665241
NEW YORK, NY
Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,108,160
-$5,626,677 QoQ
Shares Held
710,816
-46.9% QoQ
Ownership
0.278%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#55
of 316 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $64,099,635 across 21 Drug Manufacturers - Specialty & Generic names. BCRX ranks #3 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HROW |
Harrow, Inc.
|
319,625 | $13,574,473 | |
| 2 | ALKS |
Alkermes plc.
|
195,174 | $10,227,117 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
710,816 | $7,108,160 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
130,982 | $5,374,191 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
305,991 | $5,296,704 | |
| 6 | ZTS |
Zoetis Inc.
|
63,752 | $4,581,218 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
41,217 | $3,411,943 | |
| 8 | HLN |
Haleon plc
|
363,872 | $3,394,925 |
All Filings in BCRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,108,160 | 710,816 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,734,837 | 1,337,693 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,103,302 | 141,449 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,266,323 | 166,841 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,746,736 | 752,984 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,591,642 | 612,219 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,637,404 | 217,740 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,300,284 | 171,090 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,797,086 | 452,603 | Shares | Sole | 2024-08-14 | |
| 2023-06-30 | $852,804 | 121,137 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $242,228 | 21,100 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,620,447 | 207,972 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,812,311 | 171,296 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,678,002 | 287,700 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $736,820 | 53,200 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $423,325 | 29,459 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,661,425 | 105,087 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $200,389 | 19,704 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $651,062 | 87,391 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $830,453 | 241,411 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $796,005 | 167,228 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||